Latest filing published 17 Jun 2026 for 삼진제약.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
박창익: trading record in brief
This profile gathers the share dealings of 박창익 in 삼진제약, where the filings describe the role as chief executive. We count 2 filings; the first trade dates from 13 April 2026 and the latest from 17 June 2026.
The open-market record is one-sided, with 2 purchases worth €21k and not one sale. The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The newest entry dates from 17 June 2026: an open-market purchase, in 삼진제약. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Companies and markets linked to 박창익
Open company profiles for insider transactions, fundamentals and analyst consensus when available.